GLUL and cancer: In an orthotopic mouse model for ovarian carcinoma, the simultaneous depletion of glutamine synthetase (GS), upregulated in CAFs during metabolic coupling, and glutaminase (GLS), expressed in cancer cells, results in a greater reduction of tumour growth and metastasis with respect to monotherapy.